Keywords: biomarin, 2nd-qtr, loss, widens, 9m, usa-based, pharmaceutical
BioMarin's 2nd-qtr 2007 loss widens to $3.9M
Article | 20 August 2007
USA-based BioMarin Pharmaceutical says that, for the second quarter of 2007, its net loss was $3.9 million, or $0.04 per share, versus $1.3 million, $0.02 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
